GPX7 and glioblastoma: Intriguingly, our data showed that higher GPX7 expression was significantly correlated with 1p/19q non-codeleted group, carrying concomitant gain of chr7/loss of chr10, mostly seen in GBM patients (Fig. 3a; Supplementary Fig. S1).